Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 14/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 13/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 12/20 | 0.56 |
| ▸ | NCOR2 | Q9Y618 | 8/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 6/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.56 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.56 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.56 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.56 |
| ▸ | TET3 | O43151 | 1/20 | 0.56 |
| ▸ | BRD4 | O60885 | 1/20 | 0.56 |
| ▸ | FOXO1 | Q12778 | 1/20 | 0.56 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.56 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.56 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18415623 | 0.89 | HDAC1 (0.55) | HDAC1HDAC2HDAC3NCOR2HDAC4 | |
| SCHEMBL20232415 | 0.86 | HDAC1 (0.69) | HDAC1HDAC2HDAC3NCOR2HDAC4 | |
| SCHEMBL13950008 | 0.80 | HDAC1 (0.75) | HDAC1HDAC2HDAC3NCOR2HDAC4 | |
| SCHEMBL23054972 | 0.79 | HDAC1 (0.52) | HDAC1HDAC2HDAC3NCOR2HDAC4 | |
| SCHEMBL23054971 | 0.78 | HDAC1 (0.55) | HDAC1HDAC2HDAC3NCOR2HDAC4 | |
| SCHEMBL23054983 | 0.76 | ATM (0.59) | HDAC1HDAC2HDAC3NCOR2HDAC4 | |
| SCHEMBL23054956 | 0.75 | HDAC1 (0.53) | HDAC1HDAC2HDAC3NCOR2HDAC4 | |
| SCHEMBL18415621 | 0.74 | HDAC1 (0.53) | HDAC1HDAC2HDAC3NCOR2HDAC4 | |
| SCHEMBL23055049 | 0.74 | HDAC1 (0.53) | HDAC1HDAC2HDAC3NCOR2HDAC4 | |
| SCHEMBL18059397 | 0.74 | MAPT (0.68) | HDAC1HDAC2HDAC3NCOR2HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210060014-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | CERENO SCIENTIFIC AB (SE) | 2021-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210060014-A1 | COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS | HDAC3, HDAC1, HDAC2 | HDAC1 2/4885HDAC2 3/4885HDAC3 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.